Biotech Co. Sironax Raises $200M In Series B Funding
Beijing-based biotech company Sironax, which focuses on treatments for age-related degenerative diseases, announced Tuesday it had garnered $200 million in its Series B funding round....To view the full article, register now.
Already a subscriber? Click here to view full article